Second, this study only analyzed the expression level of RBM10 in LUAD tumor tissues and normal control via bioinformatics analysis, but has not yet analyzed the expression level of RBM10 in clinical specimens of lung adenocarcinoma and the correlation between its expression and clinicopathological features by IHC and requires to be explored in the future. The gene discussed is RBM10; the disease is neoplasm.